Literature DB >> 25745699

Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy.

Narendranath Epperla, Rafael Medina-Flores, Joseph J Mazza, Steven H Yale.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection of the human nervous system caused by the JC virus. We report what is, to the best of our knowledge, the second reported case using a combination of mefloquine and mirtazapine in a patient with non-AIDS-related PML with a good clinical outcome. Conversely, the recent trial of mefloquine in 21 patients with AIDS and 3 without AIDS failed to show a reduction of JC viral DNA levels in the cerebral spinal fluid. However, the positive clinical response seen in our patient after the initiation of this combination therapy suggests that further studies in the form of randomized controlled trials for the treatment of non-AIDS-related PML are warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25745699

Source DB:  PubMed          Journal:  WMJ        ISSN: 1098-1861


  9 in total

1.  A hitherto unrecognised case of progressive multifocal leukoencephalopathy.

Authors:  Huey Kuan Tan; Chun Hong Tang
Journal:  BMJ Case Rep       Date:  2015-07-23

2.  Progressive multifocal leukoencephalopathy during ixazomib-based chemotherapy.

Authors:  C P Sawicki; S A Climans; C C Hsia; J A Fraser
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

Review 3.  Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.

Authors:  Deanna Saylor; Arun Venkatesan
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

4.  Progressive Multifocal Leukoencephalopathy with Negative JC Virus PCR following Treatment of Follicular Lymphoma: Implications for Biologics in the Era of Targeted Cancer Therapy.

Authors:  Kimberly A Silverio; Shyam A Patel
Journal:  Case Rep Oncol Med       Date:  2015-12-15

5.  Brain Biopsy Is More Reliable than the DNA test for JC Virus in Cerebrospinal Fluid for the Diagnosis of Progressive Multifocal Leukoencephalopathy.

Authors:  Junji Ikeda; Akira Matsushima; Wataru Ishii; Tetuya Goto; Kenta Takahashi; Kazuo Nakamichi; Masayuki Saijo; Yoshiki Sekijima; Shu-Ichi Ikeda
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

6.  A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus.

Authors:  Yuichi Ishikawa; Tadamichi Kasuya; Junichi Ishikawa; Michio Fujiwara; Yasuhiko Kita
Journal:  Ther Clin Risk Manag       Date:  2018-06-26       Impact factor: 2.423

Review 7.  The Use of Antimalarial Drugs against Viral Infection.

Authors:  Sarah D'Alessandro; Diletta Scaccabarozzi; Lucia Signorini; Federica Perego; Denise P Ilboudo; Pasquale Ferrante; Serena Delbue
Journal:  Microorganisms       Date:  2020-01-08

8.  Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.

Authors:  Mathias Lutz; Arik B Schulze; Elisabeth Rebber; Stefanie Wiebe; Tarek Zoubi; Oliver M Grauer; Torsten Keßler; Andrea Kerkhoff; Georg Lenz; Wolfgang E Berdel
Journal:  Cancer Res Treat       Date:  2016-07-12       Impact factor: 4.679

9.  JC virus granule cell neuronopathy associated with Ruxolitinib: A case report and review of the literature.

Authors:  Kentaro Nakayama; Masataka Nakamura; Akiko Konishi; Satoshi Kaneko; Kazuo Nakamichi; Masayuki Saijo; Yusuke Yakushiji; Hirofumi Kusaka
Journal:  eNeurologicalSci       Date:  2020-09-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.